Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20727170

Download in:

View as

General Info

PMID
20727170